| Issue Date | Title | Type | Author(s) |
| 2013 | Absence of cardiotrophin 1 is associated with decreased age-dependent arterial stiffness and increased longevity in mice | Articulo | Lopez-Andres, N. (Natalia) ; Calvier, L. (Laurent); Labat, C. (Carlos); Fay, R. (Reynaud); Benetos, A.(Athanase); Zannad, F. (Faiez); Lacolley, P. (Patrick); Rossignol, P.(Patrick); Diez-Martinez, J. (Javier) |
| 2022 | Biomarker-based assessment of collagen cross-linking identifies patients at risk of heart failure more likely to benefit from spironolactone effects on left atrial remodelling. Insights from the HOMAGE clinical trial | Articulo | Ravassa, S. (Susana); López, B. (Begoña); Ferreira, J.P. (João Pedro); Girerd, N. (Nicolas); Bozec, E. (Erwan); Pellicori, P. (Pierpaolo); Mariottoni, B. (Beatrice); Cosmi, F. (Franco); Hazebroek, M.R. (Mark R.); Verdonschot, J.A.J. (Job A. J.); Cuthbert, J. (Joe); Petutschnigg, J. (Johannes); Moreno, M.U. (María Ujué); Heymans, S. (Stephane); Staessen, J.A. (Jan A.); Pieske, B. (Burkert); Edelmann, F. (Frank); Clark, A.L. (Andrew L.); Cleland, J.G. (John G.); Zannad, F. (Faiez); Diez, J. (Javier); Gonzalez, A. (Arantxa) |
| 2012 | Cardiotrophin 1 is involved in cardiac, vascular, and renal fibrosis and dysfunction | Articulo | Lopez-Andres, N. (Natalia); Rousseau, A.(Amélie); Akhtar, R.(Riaz); Calvier, L. (Laurent); Iñigo, C. (Carmen); Labat, C. (Carlos); Zhao, X.(Xuegen); Cruickshank, K.(Kennedy); Diez-Martinez, J. (Javier); Zannad, F. (Faiez); Lacolley, P. (Patrick); Rossignol, P.(Patrick) |
| 2018 | Rationale of the FIBROTARGETS study designed to identify novel biomarkers of myocardial fibrosis | Articulo | Ferreira, J.P. (João Pedro); Machu, J.L. (Jean-Loup); Girerd, N. (Nicolas); Jaisser, F. (Frederic); Thum, T. (Thomas); Butler, J. (Javed); Gonzalez, A. (Arantxa); Diez, J. (Javier); Heymans, S. (Stephane); McDonald, K. (Kenneth); Gyöngyösi, M. (Mariann); Firat, H. (Hueseyin); Rossignol, P.(Patrick); Pizard, A. (Anne); Zannad, F. (Faiez) |
| 2019 | Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the Committee of translational research of the heart failure association (HFA) of the european society of cardiology | Articulo | Boer, R.A. (Rudolf A.) de; Keulenaer, G. (Gilles) de; Bauersachs, J. (Johann); Brutsaert, D. (Dirk); Cleland, J.G. (John G.); Diez, J. (Javier); Du, X.J. (Xiao Jun); Ford, P. (Paul); Heinzel, F.R. (Frank R.); Lipson, K.E. (Kenneth E.); McDonagh, T. (Theresa); Lopez-Andres, N. (Natalia); Lunde, I.G. (Ida G.); Lyon, A.R. (Alexander R.); Pollesello, P. (Piero); Prasad, S.K. (Sanjay K.); Tocchetti, C.G. (Carlo G.); Mayr, M. (Manuel); Sluijter, J.P.G. (Joost P. G.); Thum, T. (Thomas); Tschöpe, C. (Carsten); Zannad, F. (Faiez); Zimmermann, W.H. (Wolfram Hubertus); Ruschitzka, F. (Frank); Filippatos, G. (Gerasimos); Lindsey, M.L. (Merry L.); Maack, C. (Christoph); Heymans, S. (Stephane) |
